Corpay insider plans Rule 144 share sale

Corpay has a notice under Rule 144 indicating that a holder plans to sell 3,600 shares of its common stock through Goldman Sachs & Co. LLC on the NYSE, with an approximate sale date of 02/17/2026 and an aggregate market value of about 1,233,036.

Rhea-AI Filing Summary

Corpay has a notice under Rule 144 indicating that a holder plans to sell 3,600 shares of its common stock through Goldman Sachs & Co. LLC on the NYSE, with an approximate sale date of 02/17/2026 and an aggregate market value of about 1,233,036.

The shares were originally acquired as compensation in the form of restricted stock units granted by the issuer between 2018 and 2020. Common shares outstanding were 69,958,056 as of the information provided, which is a baseline figure, not the amount being sold.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for CPAY disclose?

The filing discloses that a Corpay shareholder plans to sell 3,600 common shares under Rule 144. The sale is to be executed through Goldman Sachs & Co. LLC on the NYSE around February 17, 2026, with an aggregate market value of about 1,233,036.

How many Corpay (CPAY) shares are planned for sale under this Form 144?

The notice covers a proposed sale of 3,600 Corpay common shares. These shares are to be sold on the NYSE through Goldman Sachs & Co. LLC, with the transaction structured as a Rule 144 resale of previously acquired compensation-related restricted stock units.

What is the aggregate market value of the CPAY shares in this Form 144?

The aggregate market value of the 3,600 Corpay shares is listed as 1,233,036. This figure reflects the market value tied to the planned Rule 144 sale through Goldman Sachs & Co. LLC, based on the information provided in the notice.

How were the Corpay (CPAY) shares in this Rule 144 filing originally acquired?

The shares were acquired as compensation in the form of restricted stock units granted by the issuer. The acquisitions occurred on several dates in 2018, 2019, and 2020, with the consideration described as compensation rather than a cash purchase.

How many Corpay (CPAY) common shares are outstanding in this filing?

The filing lists 69,958,056 Corpay common shares as outstanding. This number serves as a baseline context for the company’s total share count and is separate from the 3,600 shares covered by the planned Rule 144 sale in the notice.

Through which broker and exchange will the CPAY Rule 144 sale occur?

The planned sale is to be executed through Goldman Sachs & Co. LLC as the broker. The transaction is expected to take place on the New York Stock Exchange (NYSE), where Corpay’s common stock is listed for trading, according to the notice details.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:35 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001495604
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Corpay, Inc.
SEC File Number	001-35004
Address of Issuer	3280 Peachtree Road Suite 2400 Atlanta GEORGIA 30305
Phone	1-770-499-0479
Name of Person for Whose Account the Securities are To Be Sold	Jeffrey S. Sloan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	3600	1233036	69958056	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/01/2020	Acquired as compensation -- Restricted Stock Units	Issuer			1275	01/01/2020	Compensation
Common	01/01/2018	Acquired as compensation -- Restricted Stock Units	Issuer			1667	01/01/2018	Compensation
Common	01/11/2019	Acquired as compensation -- Restricted Stock Units	Issuer			658	01/11/2019	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Jeffrey S. Sloan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)